Clostridium difficile colonizes alternative nutrient niches during infection across distinct murine gut environments

5 Clostridium difficile infection (CDI) has grown to be the most prevalent cause of hospital 6 acquired infection in the United States. Susceptibility to CDI is induced by recent 7 antibiotic exposure, which is known to alter the structure of the gut microbiome and to 8 affect the availability of growth nutrients in the gut. We hypothesized that C. difficile is a 9 generalist that adapts its physiology to the nutrients available within the gut. We orally 10 challenged C57BL/6 mice that previously received one of three antibiotics with C. 11 difficile and demonstrated that it was able to colonize the cecum within 18 hours of 12 infection. However, levels of both spore and toxin production, which are known to be 13 affected by nutrient availability, varied between each antibiotic treatment group. To 14 more closely investigate the specific responses of C. difficile as it colonized the cecum, 15 we performed in vivo transcriptional analysis of C. difficile from cecal content of infected 16 mice. This approach revealed variation in expression of genes that drive life-cycle 17 switches as well as metabolic pathways associated with catabolizing a variety of carbon 18 sources such as carbohydrates, amino acids, and amino sugars. To assess which 19 substrates C. difficile was most likely exploiting in each antibiotic-perturbed microbiome, 20

[1]  M. Monot,et al.  Deciphering Adaptation Strategies of the Epidemic Clostridium difficile 027 Strain during Infection through In Vivo Transcriptional Analysis , 2016, PloS one.

[2]  Isabelle Martin-Verstraete,et al.  The Regulatory Networks That Control Clostridium difficile Toxin Synthesis , 2016, Toxins.

[3]  P. Schloss,et al.  Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile , 2015, mBio.

[4]  A. Sonenshein,et al.  Integration of metabolism and virulence in Clostridium difficile. , 2015, Research in microbiology.

[5]  D. Leffler,et al.  Clostridium difficile infection. , 2015, The New England journal of medicine.

[6]  J. Meek,et al.  Burden of Clostridium difficile infection in the United States. , 2015, The New England journal of medicine.

[7]  Casey M. Theriot,et al.  Dynamics and Establishment of Clostridium difficile Infection in the Murine Gastrointestinal Tract , 2014, Infection and Immunity.

[8]  V. Young,et al.  Persistence and Toxin Production by Clostridium difficile within Human Intestinal Organoids Result in Disruption of Epithelial Paracellular Barrier Function , 2014, Infection and Immunity.

[9]  I. Martin-Verstraete,et al.  The regulatory network controlling spore formation in Clostridium difficile. , 2014, FEMS microbiology letters.

[10]  Curtis J. Donskey,et al.  Metabolomics Analysis Identifies Intestinal Microbiota-Derived Biomarkers of Colonization Resistance in Clindamycin-Treated Mice , 2014, PloS one.

[11]  Bo Li,et al.  Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection , 2014, Nature Communications.

[12]  B. Weimer,et al.  Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens , 2013, Nature.

[13]  J. Bond,et al.  Global Analysis of the Sporulation Pathway of Clostridium difficile , 2013, PLoS genetics.

[14]  Bruno Dupuy,et al.  Adaptive Strategies and Pathogenesis of Clostridium difficile from In Vivo Transcriptomics , 2013, Infection and Immunity.

[15]  W. Buckel,et al.  Effect of an Oxygen-Tolerant Bifurcating Butyryl Coenzyme A Dehydrogenase/Electron-Transferring Flavoprotein Complex from Clostridium difficile on Butyrate Production in Escherichia coli , 2013, Journal of bacteriology.

[16]  S. Clare,et al.  The agr Locus Regulates Virulence and Colonization Genes in Clostridium difficile 027 , 2013, Journal of bacteriology.

[17]  P. Dürre,et al.  Clostridium difficile Is an Autotrophic Bacterial Pathogen , 2013, PloS one.

[18]  A. Walker,et al.  Intestinal colonization resistance , 2013, Immunology.

[19]  D. Rodionov,et al.  Global transcriptional control by glucose and carbon regulator CcpA in Clostridium difficile , 2012, Nucleic acids research.

[20]  Fernanda C. Lessa,et al.  Current Status of Clostridium difficile Infection Epidemiology , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  D. Aronoff,et al.  Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains , 2011, Gut microbes.

[22]  G. Pier,et al.  RNA Isolation of Pseudomonas aeruginosa Colonizing the Murine Gastrointestinal Tract , 2011, Journal of visualized experiments : JoVE.

[23]  I. Martin-Verstraete,et al.  CcpA‐mediated repression of Clostridium difficile toxin gene expression , 2011, Molecular microbiology.

[24]  Christoph H Borchers,et al.  Effect of Antibiotic Treatment on the Intestinal Metabolome , 2011, Antimicrobial Agents and Chemotherapy.

[25]  E. Pelletier,et al.  Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence , 2010, BMC Genomics.

[26]  A. Sonenshein,et al.  Inhibiting the Initiation of Clostridium difficile Spore Germination using Analogs of Chenodeoxycholic Acid, a Bile Acid , 2010, Journal of bacteriology.

[27]  R. Lewis,et al.  Characterization of the Sporulation Initiation Pathway of Clostridium difficile and Its Role in Toxin Production , 2009, Journal of bacteriology.

[28]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[29]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[30]  Jeffrey D Goldsmith,et al.  A mouse model of Clostridium difficile-associated disease. , 2008, Gastroenterology.

[31]  T. Åkerlund,et al.  Induction of toxins in Clostridium difficile is associated with dramatic changes of its metabolism. , 2008, Microbiology.

[32]  M. Feldman,et al.  Large-scale reconstruction and phylogenetic analysis of metabolic environments , 2008, Proceedings of the National Academy of Sciences.

[33]  A. Sonenshein,et al.  Repression of Clostridium difficile toxin gene expression by CodY , 2007, Molecular microbiology.

[34]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[35]  B. Dupuy,et al.  Clostridium difficile toxin expression is inhibited by the novel regulator TcdC , 2007, Molecular microbiology.

[36]  William T. Self,et al.  Analysis of Proline Reduction in the Nosocomial Pathogen Clostridium difficile , 2006, Journal of bacteriology.

[37]  P. D. Karp,et al.  The outcomes of pathway database computations depend on pathway ontology , 2006, Nucleic acids research.

[38]  Julian Parkhill,et al.  The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome , 2006, Nature Genetics.

[39]  J. Songer,et al.  Clostridium difficile: an important pathogen of food animals. , 2006, Anaerobe.

[40]  K. Song,et al.  LuxS/autoinducer-2 quorum sensing molecule regulates transcriptional virulence gene expression in Clostridium difficile. , 2005, Biochemical and biophysical research communications.

[41]  J. Nielsen,et al.  Uncovering transcriptional regulation of metabolism by using metabolic network topology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  T. Schmidt,et al.  Antibiotic-Associated Diarrhea Accompanied by Large-Scale Alterations in the Composition of the Fecal Microbiota , 2004, Journal of Clinical Microbiology.

[43]  An-Ping Zeng,et al.  The Connectivity Structure, Giant Strong Component and Centrality of Metabolic Networks , 2003, Bioinform..

[44]  K. Wilson,et al.  Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora , 1988, Infection and immunity.

[45]  R. Freter,et al.  Mechanisms That Control Bacterial Populations in Continuous-Flow Culture Models of Mouse Large Intestinal Flora , 1983, Infection and immunity.

[46]  K. Wilson,et al.  Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile , 1982, Journal of clinical microbiology.

[47]  J. Tukey,et al.  Variations of Box Plots , 1978 .

[48]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[49]  P. Reeds,et al.  Nitrogen cycling in the gut. , 1998, Annual review of nutrition.